In a recent study published in the journal Nature Medicine, an international team of researchers evaluated the efficacy, safety, and tolerability of extended-release ketamine tablets (R-107) in adult ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

WESTON, Fla., June 5, 2020 /PRNewswire/ - Apotex is expanding the previously announced Retail Level recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg that was initiated on May 29, ...

Credit: FDA. The letter states that the application cannot be approved in its present form. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Incyte regarding the ...

AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) announces the launch of ...

October 7, 2010 — The US Food and Drug Administration (FDA) has approved clonidine hydrochloride, 0.1-mg and 0.2-mg, extended-release tablets (Kapvay; Shionogi Inc ...

1 st and only once-daily combination containing the active ingredient of TOPROL-XL ® (metoprolol succinate) ER tablets plus low-dose hydrochlorothiazide, offers the dual efficacy of a beta blocker and ...

Granules India Ltd on Thursday said its arm Granules Pharmaceuticals, Inc has received tentative approval from the US health regulator for its generic amphetamine extended-release tablets indicated ...

Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved XELJANZ ® XR extended-release 11 mg and 22 mg tablets for the once-daily treatment of adult patients with moderately ...

PacificNorthwest Naturals was hit with a false advertising class action Tuesday in New York Eastern District Court over its 'Genius Brand' extended-release caffeine supplements. The complaint, filed ...